Noncontact detection of ocular melanoma withl-3-123I-Iodo-α-methyltyrosine: First clinical results

Abstract

The results of the first clinical trial are presented of the newly designed tumor-seeking radiopharmaceuticall-3-123I-iodo-α-methyltyrosine (IMT) for noncontact detection of malignant eye melanoma by means of a nuclear medicine technique. Eye scintigraphy (ES) was performed on ten outpatients clinically suspected of harboring an intraocular melanoma. ES was… (More)
DOI: 10.1007/BF02152302

Topics

7 Figures and Tables

Slides referencing similar topics